Related Experiment Video
Updated: May 8, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins
Scott Nadeau1, Wei An, Nick Palermo
1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA ; Departments of Genetics, Cell Biology & Anatomy, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA.
Cbl proteins are crucial tumor suppressors regulating protein tyrosine kinase signaling. Mutations in Cbl proteins drive cancer, offering new therapeutic targets for myelodysplastic/myeloproliferative disorders.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Cbl proteins (Cbl, Cbl-b, Cbl-c) are E3 ubiquitin ligases.
- They act as negative regulators of protein tyrosine kinase (PTK) signaling.
- PTK signaling is critical in oncogenesis, and Cbl proteins function as tumor suppressors.
Purpose of the Study:
- To discuss signaling mechanisms of mutant Cbl-driven oncogenesis.
- To explore the role of Cbl proteins in cancer.
- To provide insights into targeted therapies for Cbl-mutant cancers.
Main Methods:
- Analysis of cell culture studies.
- In vivo model studies.
- Clinical data analysis.
Main Results:
- Cbl proteins target activated PTKs and signaling components for ubiquitination.
- Mutations in Cbl proteins are found in ~5% of leukemia patients with myelodysplastic/myeloproliferative disorders.
- Mutant Cbl proteins can drive oncogenesis through altered signaling pathways.
Conclusions:
- Understanding oncogenic Cbl mutants is key to comprehending hematopoietic stem cell homeostasis.
- Mutant Cbl proteins represent potential therapeutic targets for specific cancers.
- Further research into Cbl mutants may lead to novel cancer treatments.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Induced Pluripotent Stem Cells
Somatic cells are...

